S183: PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

Detalles Bibliográficos
Autores principales: Scheinberg, Phillip, Cle, Diego, Edwards, John, Giai, Valentina, Hus, Marek, Kim, Jin Seok, Lekue, Cristina Barrenetxea, Nagy, Zsolt, Nur, Erfan, Panse, Jens, Ueda, Yasutaka, Yenerel, Mustafa Nuri, Appius, Anita, Balachandran, Nadiesh, Chebon, Sammy, Gentile, Brittany, Buatois, Simon, Kulasekararaj, Austin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428303/
http://dx.doi.org/10.1097/01.HS9.0000967644.45540.d8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428303/
http://dx.doi.org/10.1097/01.HS9.0000967644.45540.d8

Ejemplares similares